Christopher R Weil
Overview
Explore the profile of Christopher R Weil including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
26
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Okwundu N, Weil C, Soares H, Fine G, Cannon D
Front Nucl Med
. 2024 Oct;
3:1074948.
PMID: 39355023
Neuroendocrine tumors (NETs) rarely metastasize to the brain. However, when they occur, NET brain metastases are associated with a poor prognosis. Due to their low incidence, NET brain metastases are...
2.
Gravbrot N, Rock C, Weil C, Rock C, Burt L, DeCesaris C, et al.
World Neurosurg
. 2024 May;
188:e259-e266.
PMID: 38777319
Objective: Surgical resection is the mainstay of treatment for WHO grade 2 meningioma. Fractionated radiation therapy (RT) is frequently used after surgery, though many centers utilize stereotactic radiosurgery (SRS) for...
3.
Roach E, Weil C, Cannon G, Grant J, Van Meter M, Boothe D
Ann Surg Oncol
. 2024 Apr;
31(7):4527-4539.
PMID: 38647915
Background: For breast cancer with advanced regional lymph node involvement, axillary lymph node dissection (ALND) remains the standard of care for staging and treating the axilla despite the presence of...
4.
Gravbrot N, Weil C, DeCesaris C, Gaffney D, Suneja G, Burt L
Eur J Cancer
. 2024 Apr;
202:114017.
PMID: 38570289
No abstract available.
5.
Gravbrot N, Weil C, DeCesaris C, Gaffney D, Suneja G, Burt L
Eur J Cancer
. 2024 Feb;
201:113913.
PMID: 38377777
Objectives: The International Federation of Gynecology and Obstetrics (FIGO) staging system for endometrial cancer underwent revision in 2023, incorporating histology, lymphovascular space invasion, and molecular classification. Herein, we compare overall...
6.
Rock C, Weil C, Rock C, Gravbrot N, Burt L, DeCesaris C, et al.
J Clin Neurosci
. 2024 Jan;
120:175-180.
PMID: 38262262
Background: We analyzed long-term control and patterns of failure in patients with World Health Organization Grade 1 meningiomas treated with definitive or postoperative stereotactic radiosurgery at the authors' affiliated institution....
7.
Hutten R, Weil C, King A, Barney B, Bylund C, Fagerlin A, et al.
JCO Oncol Pract
. 2023 Sep;
19(11):1000-1008.
PMID: 37722084
Purpose: Complementary and alternative medicine (CAM) use during cancer treatment is controversial. We aim to evaluate contemporary CAM use, patient perceptions and attitudes, and trust in various sources of information...
8.
Lee S, Weil C, Boyd L, DeCesaris C, Gaffney D, Suneja G
Int J Gynecol Cancer
. 2023 Jul;
33(9):1408-1418.
PMID: 37487661
Objective: To explore the use of Gynecologic Oncology Group 258 (GOG 258) study regimens before, during, and after the study. Methods: Patients aged 18 years or older with endometrial cancer...
9.
Kraus R, Weil C, Abdel-Wahab M
JCO Glob Oncol
. 2022 Dec;
8:e2200215.
PMID: 36525619
No abstract available.
10.
Weil C, Lew F, Williams V, Burt L, Ermoian R, Poppe M
Adv Radiat Oncol
. 2022 Nov;
7(6):100868.
PMID: 36420204
Purpose: Proton radiation therapy (PR) is well established in the treatment of pediatric malignancies in the central nervous system (CNS) with dosimetric advantages that reduce late radiation therapy (RT) effects....